ICON Public Limited Company (ICLR) Surges on Net Book-to-Bill Strength

1 month ago 12

Soumya Eswaran

Wed, July 29, 2026 astatine 8:16 AM CDT 3 min read

Harris Oakmark precocious released its second-quarter 2026 capitalist missive for the "Oakmark U.S. Concentrated Strategy". A transcript of the missive tin beryllium downloaded here. The strategy returned 9.21% (net) successful the 2nd quarter, lagging the Russell 1000 Value Index's 13.87%. U.S. equities finished higher during the quarter, with 9 of eleven GICS sectors posting gains, led by exertion and industrials, portion vigor and utilities detracted. The marketplace showed concentrated leadership, with investors favoring companies that payment from AI spending. However, the steadfast continues to absorption connected worth discipline, avoiding AI-driven marketplace fads, prioritizing companies trading beneath intrinsic value. In addition, delight cheque the Strategy's apical 5 holdings to cognize its champion picks successful 2026.

In its Q2 2026 capitalist letter, Oakmark U.S. Concentrated Strategy highlighted ICON Public Limited Company (NASDAQ:ICLR). ICON Public Limited Company (NASDAQ:ICLR) is simply a objective probe enactment that provides outsourced improvement and commercialization services to the pharmaceutical, biotechnology, and aesculapian instrumentality industries. On July 28, 2026, ICON Public Limited Company (NASDAQ:ICLR) banal closed astatine $180.24 per share. One-month instrumentality of ICON Public Limited Company (NASDAQ:ICLR) was 2.96%, and its shares mislaid 0.69% implicit the past 52 weeks. ICON Public Limited Company (NASDAQ:ICLR) has a marketplace capitalization of astir $13.91 billion.

Oakmark U.S. Concentrated Strategy stated the pursuing regarding ICON Public Limited Company (NASDAQ:ICLR) successful its Q2 2026 capitalist update:

"ICON Public Limited Company (NASDAQ:ICLR) was a contributor during the quarter. The Ireland-headquartered and U.S.-listed objective probe enactment reported 2 sets of results arsenic it caught up pursuing its accounting re view, some successful enactment with expectations against an improving pharma backdrop. Bookings were the standout, with a beardown nett book-to-bill and sharply little cancellations than a twelvemonth ago, led by full-service outsourcing. Given the business's long-cycle nature, this should enactment accelerating gross maturation successful coming years if sustained. Margins met guidance, and absorption is assured successful further gains from steps al acceptable underway. With the accounting clean-up down it, ICON plans to resume buybacks, its apical superior priority, aft adjacent quarter's earnings. We proceed to spot ICON arsenic the starring axenic play successful an charismatic manufacture with a agelong runway for aboriginal growth."

 Among Small-Cap Healthcare Stocks Hedge Funds is Buying

ICON Public Limited Company (ICLR): Among Small-Cap Healthcare Stocks Hedge Funds is Buying

ICON Public Limited Company (NASDAQ:ICLR) is not connected our database of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 49 hedge money portfolios held ICON Public Limited Company (NASDAQ:ICLR) astatine the extremity of the archetypal quarter, up from 41 successful the erstwhile quarter. While we admit the imaginable of ICON Public Limited Company (NASDAQ:ICLR) arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

Read Entire Article